Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c740 |
|---|---|
| Identifier | NCT06850727 |
| Trial Title | A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|UC - Ulcerative Colitis |
| Interventions | DRUG: OD-07656|DRUG: Vedolizumab |
Participant Information
| Sponsor | Odyssey Therapeutics |
|---|---|
| City | Melbourne |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-25 |
|---|---|
| Primary Completion Date | 2025-01-26 |
| Completion Date | 2025-11-26 |